« Back
Third Quarter Results for Fiscal 2015
Jul 29, 2015
Key highlights:
-
Closed the previously announced acquisition of the
Comverse business support systems (BSS) assets onJuly 2, 2015 , for$273 million in cash -
Third fiscal quarter revenue of
$908 million , within the$885-$925 million guidance range. Revenue was in line with the midpoint of expectations, excluding foreign currency movements. Foreign currency movements positively affected revenue by approximately$1 million relative to the second quarter of fiscal 2015 -
Third fiscal quarter non-GAAP operating income of
$155 million ; non-GAAP operating margin of 17.1%; GAAP operating income of$127 million -
Third fiscal quarter diluted non-GAAP EPS of
$0.84 ,two cents above midpoint of the$0.79-$0.85 guidance range, excluding amortization of purchased intangible assets and other acquisition-related costs and equity-based compensation expense, net of related tax effects -
Diluted GAAP EPS of
$0.69 for the third fiscal quarter, within the$0.65-$0.73 guidance range -
Strong free cash flow of
$190 million for the third fiscal quarter -
Repurchased
$60 million of ordinary shares during the third fiscal quarter -
Twelve-month backlog of
$3.01 billion at the end of the third fiscal quarter, up$10 million from the end of the second quarter of fiscal 2015 -
The Board of Directors approved a
$0.17 per share quarterly cash dividend to be paid onOctober 16, 2015 -
Fourth quarter fiscal 2015 guidance: Expected revenue of approximately
$915-$955 million , including the acquired Comverse BSS assets. Expected diluted non-GAAP EPS of approximately$0.79-$0.85 , excluding amortization of purchased intangible assets and other acquisition-related costs, at least$0.09 per share of nonrecurring restructuring charges associated with the acquisition of the Comverse BSS assets, and approximately$0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Expected diluted GAAP EPS of approximately$0.49-$0.59 . The impact on diluted GAAP EPS of the acquisition of the Comverse BSS assets is subject to finalization of the purchase price allocation byAmdocs -
Full year fiscal 2015 revenue guidance: Expects fiscal 2015 revenue growth, on a constant currency basis, towards the midpoint of the guidance range provided on
November 4, 2014 of 2.5% to 5.5% year-over-year. Expects fiscal 2015 reported revenue growth of 2.0% to 3.0% year-over-year
"We are pleased with our solid results for the third fiscal quarter and the continued progress we have made executing on our various growth initiatives. During the quarter, we expanded our product suite with the launch of CES 9.3 and renewed several managed services agreements which broaden those customer relationships for the long-term. At the same time, we remained focused on our delivery and execution, such as the recently completed migration of FarEastTone's prepaid subscribers to an advanced
Gelman continued, "Shortly after the close of the third quarter, we completed the acquisition of a substantial majority of
Gelman concluded, "We enter our fourth fiscal quarter with a strong win rate for the year to date. Uncertainty persists as a result of consolidation activity in our key markets, but our competitive position remains strong and we expect to benefit once trends improve. Additionally, our consistent focus on operational and financial execution continues to manifest in strong free cash flow generation. Combined with our commitment to proactively allocate capital over the short and long-term, we believe that we can deliver diluted non-GAAP earnings per share growth towards the midpoint of our previously guided range of 4.5% to 7.5% for the full fiscal year 2015."
Financial Discussion of Third Fiscal Quarter Results
Free cash flow was
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was
Financial Outlook
Diluted earnings per share on a non-GAAP basis for the fourth fiscal quarter is expected to be
Quarterly Cash Dividend Program
On
Conference Call Details
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:
- amortization of purchased intangible assets and other acquisition-related costs;
- changes in fair value of certain acquisition-related liabilities;
-
nonrecurring restructuring charges associated with the
Comverse acquisition; - equity-based compensation expense; and
- tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles.
For its internal budgeting process and in monitoring the results of the business,
About
For more than 30 years,
For more information, visit
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about
AMDOCS LIMITED | ||||
Consolidated Statements of Income | ||||
(in thousands, except per share data) | ||||
Three months ended | Nine months ended | |||
June 30, | June 30, | |||
2015 | 2014 | 2015 | 2014 | |
Revenue | $907,897 | $902,477 | $2,716,762 | $2,663,376 |
Operating expenses: | ||||
Cost of revenue | 592,366 | 584,604 | 1,746,383 | 1,725,291 |
Research and development | 62,598 | 64,863 | 189,044 | 190,292 |
Selling, general and administrative | 108,128 | 112,681 | 328,894 | 335,078 |
Amortization of purchased intangible assets and other | 18,078 | 15,326 | 46,193 | 43,174 |
781,170 | 777,474 | 2,310,514 | 2,293,835 | |
Operating income | 126,727 | 125,003 | 406,248 | 369,541 |
Interest and other expense, net | 1,044 | 748 | 1,169 | 4,060 |
Income before income taxes | 125,683 | 124,255 | 405,079 | 365,481 |
Income taxes | 17,901 | 14,428 | 50,046 | 43,862 |
Net income | $107,782 | $109,827 | $355,033 | $321,619 |
Basic earnings per share | $0.70 | $0.69 | $2.29 | $2.02 |
Diluted earnings per share | $0.69 | $0.68 | $2.26 | $1.99 |
Basic weighted average number of shares outstanding | 154,101 | 159,257 | 155,037 | 159,574 |
Diluted weighted average number of shares outstanding | 156,581 | 161,725 | 157,352 | 161,939 |
Cash dividends declared per share | $0.170 | $0.155 | $0.495 | $0.440 |
AMDOCS LIMITED | ||||
Selected Financial Metrics | ||||
(in thousands, except per share data) | ||||
Three months ended | Nine months ended | |||
June 30, | June 30, | |||
2015 | 2014 | 2015 | 2014 | |
Revenue | $907,897 | $902,477 | $2,716,762 | $2,663,376 |
Non-GAAP operating income | 155,305 | 150,849 | 461,758 | 446,735 |
Non-GAAP net income | 131,215 | 130,919 | 399,347 | 385,333 |
Non-GAAP diluted earnings per share | $0.84 | $0.81 | $2.54 | $2.38 |
Diluted weighted average number of shares outstanding | 156,581 | 161,725 | 157,352 | 161,939 |
AMDOCS LIMITED | |||||
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP | |||||
(in thousands) | |||||
Three months ended | |||||
June 30, 2015 | |||||
Reconciliation items | |||||
GAAP | Amortization of | Equity based | Tax effect | Non-GAAP | |
purchased | compensation | ||||
intangible assets | expense | ||||
and other | |||||
Operating expenses: | |||||
Cost of revenue | $592,366 | $ - | $ (3,786) | $ - | $588,580 |
Research and development | 62,598 | - | (816) | - | 61,782 |
Selling, general and administrative | 108,128 | - | (5,898) | - | 102,230 |
Amortization of purchased intangible assets and other | 18,078 | (18,078) | -- | - | - |
Total operating expenses | 781,170 | (18,078) | (10,500) | - | 752,592 |
Operating income | 126,727 | 18,078 | 10,500 | - | 155,305 |
Income taxes | 17,901 | - | - | 5,145 | 23,046 |
Net income | $107,782 | $18,078 | $10,500 | $(5,145) | $131,215 |
Three months ended | |||||
June 30, 2014 | |||||
Reconciliation items | |||||
GAAP | Amortization of | Equity based | Tax effect | Non-GAAP | |
purchased | compensation | ||||
intangible assets | expense | ||||
and other | |||||
Operating expenses: | |||||
Cost of revenue | $584,604 | $ - | $ (4,297) | $ - | $580,307 |
Research and development | 64,863 | - | (880) | - | 63,983 |
Selling, general and administrative | 112,681 | - | (5,343) | - | 107,338 |
Amortization of purchased intangible assets and other | 15,326 | (15,326) | -- | - | - |
Total operating expenses | 777,474 | (15,326) | (10,520) | - | 751,628 |
Operating income | 125,003 | 15,326 | 10,520 | - | 150,849 |
Income taxes | 14,428 | - | - | 4,754 | 19,182 |
Net income | $109,827 | $15,326 | $10,520 | $(4,754) | $130,919 |
AMDOCS LIMITED | ||||||
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP | ||||||
(in thousands) | ||||||
Nine months ended | ||||||
June 30, 2015 | ||||||
Reconciliation items | ||||||
GAAP | Amortization of | Equity based | Changes in fair | Tax effect | Non-GAAP | |
purchased | compensation | value of certain | ||||
intangible | expense | acquisition- | ||||
assets and other | related liabilities | |||||
Operating expenses: | ||||||
Cost of revenue | $1,746,383 | $ - | $ (11,767) | $24,906 | $ - | $1,759,522 |
Research and development | 189,044 | - | (2,570) | - | - | 186,474 |
Selling, general and administrative | 328,894 | - | (19,886) | - | - | 309,008 |
Amortization of purchased intangible assets and other | 46,193 | (46,193) | - | - | - | - |
Total operating expenses | 2,310,514 | (46,193) | (34,223) | 24,906 | - | 2,255,004 |
Operating income | 406,248 | 46,193 | 34,223 | (24,906) | - | 461,758 |
Interest and other expense, net | 1,169 | - | - | 3,921 | - | 5,090 |
Income taxes | 50,046 | - | - | - | 7,275 | 57,321 |
Net income | $355,033 | $46,193 | $34,223 | $ (28,827) | $ (7,275) | $399,347 |
Nine months ended | |||||
June 30, 2014 | |||||
Reconciliation items | |||||
GAAP | Amortization of | Equity based | Tax effect | Non-GAAP | |
purchased | compensation | ||||
intangible assets | expense | ||||
and other | |||||
Operating expenses: | |||||
Cost of revenue | $1,725,291 | $ - | $ (13,220) | $ - | $1,712,071 |
Research and development | 190,292 | - | (2,685) | - | 187,607 |
Selling, general and administrative | 335,078 | - | (18,115) | - | 316,963 |
Amortization of purchased intangible assets and other | 43,174 | (43,174) | - | - | - |
Total operating expenses | 2,293,835 | (43,174) | (34,020) | - | 2,216,641 |
Operating income | 369,541 | 43,174 | 34,020 | - | 446,735 |
Income taxes | 43,862 | - | - | 13,480 | 57,342 |
Net income | $321,619 | $43,174 | $34,020 | $ (13,480) | $385,333 |
AMDOCS LIMITED | ||
Condensed Consolidated Balance Sheets | ||
(in thousands) | ||
As of | ||
June 30, | September 30, | |
2015 | 2014 | |
ASSETS | ||
Current assets | ||
Cash, cash equivalents and short-term interest-bearing investments | $ 1,401,708 | $ 1,424,465 |
Accounts receivable, net, including unbilled of $96,355 and $134,523, respectively | 739,927 | 715,837 |
Deferred income taxes and taxes receivable | 182,422 | 148,346 |
Prepaid expenses and other current assets | 130,957 | 135,326 |
Total current assets | 2,455,014 | 2,423,974 |
Equipment and leasehold improvements, net | 286,183 | 288,956 |
Goodwill and other intangible assets, net | 2,071,678 | 2,106,452 |
Other noncurrent assets | 355,452 | 365,895 |
Total assets | $ 5,168,327 | $ 5,185,277 |
LIABILITIES AND SHAREHOLDERS' EQUITY | ||
Current liabilities | ||
Accounts payable, accruals and other | $ 850,533 | $ 785,548 |
Short-term financing arrangements | -- | 210,000 |
Deferred revenue | 174,425 | 156,743 |
Deferred income taxes and taxes payable | 76,434 | 48,456 |
Total current liabilities | 1,101,392 | 1,200,747 |
Other noncurrent liabilities | 550,634 | 588,694 |
Shareholders' equity | 3,516,301 | 3,395,836 |
Total liabilities and shareholders' equity | $ 5,168,327 | $ 5,185,277 |
AMDOCS LIMITED | ||
Consolidated Statements of Cash Flows | ||
(in thousands) | ||
Nine months ended June 30, | ||
2015 | 2014 | |
Cash Flow from Operating Activities: | ||
Net income | $355,033 | $321,619 |
Reconciliation of net income to net cash provided by operating activities: | ||
Depreciation and amortization | 123,136 | 116,911 |
Equity-based compensation expense | 34,223 | 34,020 |
Deferred income taxes | (22,797) | (5,336) |
Excess tax benefit from equity-based compensation | (4,040) | (574) |
Loss from short-term interest-bearing investments | 275 | 737 |
Net changes in operating assets and liabilities, net of amounts acquired: | ||
Accounts receivable | (22,081) | (40,570) |
Prepaid expenses and other current assets | 12,612 | 2,828 |
Other noncurrent assets | 1,310 | (17,639) |
Accounts payable, accrued expenses and accrued personnel | 78,395 | 25,955 |
Deferred revenue | 6,597 | 55,625 |
Income taxes payable | 18,498 | 5,802 |
Other noncurrent liabilities | (15,314) | 16,980 |
Net cash provided by operating activities | 565,847 | 516,358 |
Cash Flow from Investing Activities: | ||
Payments for purchase of equipment and leasehold improvements, net | (91,501) | (77,881) |
Proceeds from sale of short-term interest-bearing investments | 180,758 | 284,926 |
Purchase of short-term interest-bearing investments | (184,724) | (294,091) |
Net cash paid for acquisitions | (8,099) | (180,540) |
Other | 931 | 3,348 |
Net cash used in investing activities | (102,635) | (264,238) |
Cash Flow from Financing Activities: | ||
Payments under financing arrangements | (210,000) | (200,000) |
Repurchase of shares | (272,211) | (261,916) |
Proceeds from employee stock options exercised | 62,951 | 116,041 |
Payments of dividends | (74,663) | (66,363) |
Excess tax benefit from equity-based compensation | 4,040 | 574 |
Other | (7) | (710) |
Net cash used in financing activities | (489,890) | (412,374) |
Net decrease in cash and cash equivalents | (26,678) | (160,254) |
Cash and cash equivalents at beginning of period | 1,103,269 | 1,014,192 |
Cash and cash equivalents at end of period | $1,076,591 | $853,938 |
AMDOCS LIMITED | |||||
Supplementary Information | |||||
(in millions) | |||||
Three months ended | |||||
June 30, | March 31, | December 31, | September 30, | June 30, | |
2015 | 2015 | 2014 | 2014 | 2014 | |
North America | $ 623.1 | $ 646.7 | $ 659.1 | $ 662.7 | $ 647.2 |
Europe | 102.3 | 97.6 | 106.9 | 105.3 | 114.6 |
Rest of the World | 182.5 | 158.3 | 140.3 | 132.3 | 140.7 |
Total Revenue | $ 907.9 | $ 902.6 | $ 906.3 | $ 900.3 | $ 902.5 |
Three months ended | |||||
June 30, | March 31, | December 31, | September 30, | June 30, | |
2015 | 2015 | 2014 | 2014 | 2014 | |
Managed Services Revenue | $ 460.6 | $ 448.8 | $ 467.1 | $ 436.4 | $ 438.0 |
Three months ended | |||||
June 30, | March 31, | December 31, | September 30, | June 30, | |
2015 | 2015 | 2014 | 2014 | 2014 | |
Customer Experience | $ 883.7 | $ 877.1 | $ 882.4 | $ 871.5 | $ 870.8 |
Systems | |||||
Directory | 24.2 | 25.5 | 23.9 | 28.8 | 31.7 |
Total Revenue | $ 907.9 | $ 902.6 | $ 906.3 | $ 900.3 | $ 902.5 |
As of | |||||
June 30, | March 31, | December 31, | September 30, | June 30, | |
2015 | 2015 | 2014 | 2014 | 2014 | |
12-Month Backlog | $ 3,010 | $ 3,000 | $ 3,030 | $ 3,000 | $ 2,970 |
CONTACT:Matthew Smith Head of Investor RelationsAmdocs 314-212-8328 E-mail: dox_info@amdocs.com